INR:0494. is today match Novartis Piqray for PIK3CA mutation HR+/HER2- breast cancer: significantly prolonged survival The National Medical Insurance Bureau has re ...
INR:3407. mpl game online play FDA approves first topical minocycline treatment for rosacea Grifols acquires proteomics startup for $146 million Interpretati ...
rummy cluchar ORR reached 32%! Phase IIa results of a new CXCR4 antagonist combined with Keytruda for pancreatic cancer were released Official announcement: 21 major categories of consumables are ...